Search results
Results From The WOW.Com Content Network
Age-related macular degeneration (AMD) is an eye disease that can blur your central vision. It happens when aging causes damage to the macula — the part of the eye that controls sharp, straight-ahead vision. The macula is part of the retina (the light-sensitive tissue at the back of the eye). AMD is a common condition — it’s a leading ...
This booklet is for people with age-related macular degeneration (AMD) and their families and friends. It provides information about AMD and answers questions about its causes, symptoms, stages and treatment. (26 pages) Topics: AREDS/AREDS2 Age-Related Macular Degeneration Vision Rehabilitation. Material Type:
AMD is a common eye condition and a leading cause of vision loss among people age 60 and older. It causes damage to the macula, a small spot near the center of the retina and the part of the eye needed for sharp, central vision, which lets us see objects that are straight ahead.
Researchers at the National Eye Institute (NEI) are launching a clinical trial to test the safety of a novel patient-specific stem cell-based therapy to treat geographic atrophy, the advanced “dry” form of age-related macular degeneration (AMD), a leading cause of vision loss among people age 65 and older.
New research offers hope for preventing age-related blindness. October 2, 2024. Age-Related Macular Degeneration. Basic Research. Grantee. Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in the United States. Despite existing treatments, the underlying causes of this disease and effective therapies remain ...
Age-related macular degeneration (AMD) is an eye disease that can blur the center of your vision. If you have intermediate AMD in 1 or both eyes, special dietary supplements called AREDS 2 can help slow down vision loss.
Age-related macular degeneration (AMD) is an eye disease that can blur the center of your vision. Wet AMD (also called advanced neovascular AMD) is a serious type of late AMD. It happens when a protein called vascular endothelial growth factor (VEGF) makes abnormal blood vessels grow in the wrong place in the back of your eye.
Moeller SM, Parekh N, et al; CAREDS Research Study Group. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol. 2006 Aug;124(8):1151-62. doi: 10.1001/archopht.124.8.1151.
The Age-Related Eye Disease Study (AREDS) and AREDS2 are major clinical trials sponsored by the National Eye Institute. The AREDS studies were designed to learn more about the natural history and risk factors of age-related macular degeneration (AMD) and cataract and to evaluate the effect of vitamins on the progression of these eye diseases.
Research in this area is a high priority of the Institute; in fiscal year 1997, the NEI is funding approximately $75 million of research in areas generally related to age-related macular degeneration. Of this amount, approximately $16 million is directly related to AMD. This $16 million figure represents a 333 percent increase from the $5 ...